Optimizing vedolizumab therapy in ulcerative colitis: A critical synthesis of trial evidence and the emerging role of artificial intelligence
The strategic integration of AI-driven predictive analytics with vedolizumab's clinical and pharmacodynamic data represents a pivotal next step towards achieving true precision medicine in UC.
Authors
- Alfadl A Abdulfattah
Institutions
- Jazan University (SA)
Publication Details
- Journal
- PLOS Digital Health
- Published
- 2026-02-05
- DOI
- https://doi.org/10.1371/journal.pdig.0001208
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00